BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37566018)

  • 1. Plasma Sphingomyelin Disturbances: Unveiling Its Dual Role as a Crucial Immunopathological Factor and a Severity Prognostic Biomarker in COVID-19.
    Toro DM; da Silva-Neto PV; de Carvalho JCS; Fuzo CA; Pérez MM; Pimentel VE; Fraga-Silva TFC; Oliveira CNS; Caruso GR; Vilela AFL; Nobre-Azevedo P; Defelippo-Felippe TV; Argolo JGM; Degiovani AM; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; Rocha JJRD; Feres O; Costa GP; Maruyama SRC; Russo EMS; Fernandes APM; Santos IKFM; Malheiro A; Sadikot RT; Bonato VLD; Cardoso CRB; Dias-Baruffi M; Trapé ÁA; Faccioli LH; Sorgi CA; ImmunoCovid Consortium Group
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
    Dobierzewska A; Soman S; Illanes SE; Morris AJ
    PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide and sphingomyelin species of fibroblasts and neurons in culture.
    Valsecchi M; Mauri L; Casellato R; Prioni S; Loberto N; Prinetti A; Chigorno V; Sonnino S
    J Lipid Res; 2007 Feb; 48(2):417-24. PubMed ID: 17093290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma sphingomyelin (d18:1/22:0) is closely related to hepatic steatosis in patients with chronic hepatitis C virus infection.
    Li JF; Qu F; Zheng SJ; Wu HL; Liu M; Liu S; Ren Y; Ren F; Chen Y; Duan ZP; Zhang JL
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1725-32. PubMed ID: 24810965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells.
    Shammout ODA; Ashmawy NS; Shakartalla SB; Altaie AM; Semreen MH; Omar HA; Soliman SSM
    PLoS One; 2021; 16(10):e0258363. PubMed ID: 34637456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway.
    Foghi A; Ravandi A; Teerds KJ; Van Der Donk H; Kuksis A; Dorrington J
    Endocrinology; 1998 Apr; 139(4):2041-7. PubMed ID: 9528992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
    Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
    JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential serum sphingolipid biomarkers for distinguishing Wilson disease.
    Tang S; Liang C; Yu H; Hou W; Hu Z; Chen X; Duan Z; Zheng S
    Clin Chim Acta; 2024 Jan; 553():117740. PubMed ID: 38145643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of plasma glycerophospholipid and sphingolipid species in male alcohol-dependent patients.
    Reichel M; Hönig S; Liebisch G; Lüth A; Kleuser B; Gulbins E; Schmitz G; Kornhuber J
    Biochim Biophys Acta; 2015 Nov; 1851(11):1501-10. PubMed ID: 26291032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible roles of long-chain sphingomyelines and sphingomyelin synthase 2 in mouse macrophage inflammatory response.
    Sakamoto H; Yoshida T; Sanaki T; Shigaki S; Morita H; Oyama M; Mitsui M; Tanaka Y; Nakano T; Mitsutake S; Igarashi Y; Takemoto H
    Biochem Biophys Res Commun; 2017 Jan; 482(2):202-207. PubMed ID: 27836537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of
    den Hoedt S; Dorst-Lagerwerf KY; de Vries HE; Rozemuller AJM; Scheltens P; Walter J; Sijbrands EJG; Martinez-Martinez P; Verhoeven AJM; Teunissen CE; Mulder MT
    J Alzheimers Dis Rep; 2023; 7(1):339-354. PubMed ID: 37220621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingomyelins and ceramides: possible biomarkers for dementia?
    Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
    Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
    Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of Sphingolipids in Biofluids: Implications for Neurodegenerative Diseases.
    Pujol-Lereis LM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells.
    Momchilova A; Pankov R; Staneva G; Pankov S; Krastev P; Vassileva E; Hazarosova R; Krastev N; Robev B; Nikolova B; Pinkas A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS.
    Yang Z; Deng X; Zhu J; Chen S; Jiao C; Ruan Y
    Clin Chim Acta; 2024 Jan; 552():117652. PubMed ID: 37979606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19.
    Kurano M; Okamoto K; Jubishi D; Hashimoto H; Sakai E; Saigusa D; Kano K; Aoki J; Harada S; Okugawa S; Doi K; Moriya K; Yatomi Y
    Clin Transl Med; 2022 Oct; 12(10):e1069. PubMed ID: 36214754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
    Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
    Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.